Pei-rong R. Ding
No. 651, Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Body mass index and dyslipidemia influence responses to anti-PD-1 immunotherapy in colorectal cancer.
Journal: Annals of medicine
Published: August 25, 2026
Single-Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti-PD-1 Resistance in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 20, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 19, 2026
Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer.
Journal: BMC cancer
Published: November 23, 2025
SDC1+ CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancers.
Journal: Gut
Published: November 18, 2025
POSTN+ cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer.
Journal: Cancer letters
Published: September 03, 2025
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational Study.
Journal: Annals of surgery
Published: August 07, 2025
Surgical Outcomes in Metastatic Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer After Disease Control With Immune Checkpoint Inhibitors: A Retrospective Observational Study.
Journal: Diseases of the colon and rectum
Published: June 27, 2025
Proposal of a novel model for identifying complete response and nonoperative management in dMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: May 30, 2025
Proposal of a novel model for identifying complete response and nonoperative management in DMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: May 30, 2025
Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study.
Journal: NPJ precision oncology
Published: March 28, 2025
Last Updated: 09/26/2026